Your browser doesn't support javascript.
loading
Nucleosome assembly protein 1 like 1 (NAP1L1) promotes cardiac fibrosis by inhibiting YAP1 ubiquitination and degradation.
Li, Tianyu; Niu, Zhihui; Yu, Tong; Li, Jinrui; Lu, Xin; Huang, Mengqin; Wang, Qianqian; Yu, Xiaojiang; Feng, Jiayue; Xu, Bingqian; Bing, Danyang; Li, Xuelian; Lu, Lifang; Liang, Haihai; Yang, Rui; Wang, Bin; Shan, Hongli.
Afiliação
  • Li T; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Niu Z; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Yu T; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Li J; Shanghai Frontiers Science Research Center for Druggability of Cardiovascular noncoding RNA, Institute for Frontier Medical Technology Shanghai University of Engineering Science Shanghai China.
  • Lu X; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Huang M; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Wang Q; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Yu X; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Feng J; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Xu B; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Bing D; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Li X; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Lu L; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Liang H; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Yang R; Department of Basic Medicine, The Centre of Functional Experiment Teaching Harbin Medical University Harbin China.
  • Wang B; Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy Harbin Medical University Harbin China.
  • Shan H; Research Unit of Noninfectious Chronic Diseases in Frigid Zone (2019RU070) Chinese Academy of Medical Sciences Harbin China.
MedComm (2020) ; 4(5): e348, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37593048
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedComm (2020) Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedComm (2020) Ano de publicação: 2023 Tipo de documento: Article